Furthermore, RBM3 was found to be up-regulated in poorly differentiated prostate cancers in comparison to normal prostatic glands [14], as well as in low-grade vs high-grade astrocytomas [15]. This evidence concerns the gene RBM3 and astrocytoma (excluding glioblastoma).